Receiving Continuous Antibiotic Prophylaxis-Reference-Cited by-同舟云学术

Receiving Continuous Antibiotic Prophylaxis

Published:2020-03-01 Issue:1 Volume:25 Page:28-31
ISSN:2285-7079
Container-title:Acta Medica Transilvanica
language:en
Short-container-title:

Author:

Horga Adeline Larisa¹,Neamțu Mihai-Leonida²,Neamțu Bogdan³

Affiliation:

1. County Emergency Clinical Hospital Arad , Phd Student, “Lucian Blaga” University of Sibiu

2. Faculty of Medicine , Lucian Blaga University

3. Research and Telemedicine Center of Neurological Diseases in Children

Abstract

Abstract Continuous antibiotic prophylaxis represents an initial management strategy for decreasing the risk of urinary tract infections in children with vesicoureteral reflux. A significant number of cases resolve spontaneously in time, reason for which continuous antibiotic prophylaxis is not required in every patient with this disorder. It is mandatory to select the patients who need continuous antibiotic prophylaxis according to their risk group. We do not have a lot of scientific evidences about what is better or not for these patients, but the main objective for the case management is to maintain the renal function, by minimizing the risk of pyelonephritis, renal scars and its consequences such as hypertension or renal failure. The selection of these patients who do not require continuous antibiotic prophylaxis is difficult, and the prophylaxis remains the safest method in most of the cases. To take the best decisions for our patients, it is important to consider the last published guidelines and studies.

Publisher

Walter de Gruyter GmbH

Link

https://www.sciendo.com/pdf/10.2478/amtsb-2020-0008

Reference36 articles.

1. 1. Schwab CW Jr, Wu HY, Selman H, Smith GH, Snyder HM 3rd, Canning DA. Spontaneous resolution of vesicoureteral reflux: a 15-year perspective. J Urol. 2002;168(6):2594-9.

2. 2. Tamminen-Möbius T, Brunier E, Ebel KD, Lebowitz R, Olbing H, Seppänen U, et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. J Urol. 1992;148(5 Pt 2):1662-6.

3. 3. Van der Meer JW, Gyssens IC. Quality of antimicrobial drug prescription in hospital. Clin Microbiol Infect. 2001;7 Suppl 6:12–5. PMID: 11990686.

4. 4. CDC, Antibiotic Resistance Threats in the United States, 2013 available at www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.

5. 5. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163(8):972-978. PMID:12719208.